Home ETF List About

Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 77
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
IssuerBlackrock
ETF TickerBTEE(USD) LSE
ETF TickerBTEE.L(GBP) LSE

Holdings detail for TSHA

Stock NameTaysha Gene Therapies Inc
TickerTSHA(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS8776191061

Show aggregate TSHA holdings

News associated with TSHA

Taysha Gene Therapies (NASDAQ:TSHA) Trading Down 4.4% After Insider Selling
Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) traded down 4.4% during mid-day trading on Monday following insider selling activity. The company traded as low as $2.97 and last traded at $2.94. 386,568 shares changed hands during trading, a decline of 87% from the average session volume of 2,949,512 shares. The stock […] - 2025-09-17 02:12:53
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives $8.29 Average PT from Analysts
Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) has earned an average recommendation of “Buy” from the eight brokerages that are currently covering the company, Marketbeat.com reports. Eight analysts have rated the stock with a buy recommendation. The average twelve-month target price among brokers that have issued a report on the stock in the […] - 2025-09-05 02:52:55
Contrasting Taysha Gene Therapies (NASDAQ:TSHA) & Supernus Pharmaceuticals (NASDAQ:SUPN)
Taysha Gene Therapies (NASDAQ:TSHA – Get Free Report) and Supernus Pharmaceuticals (NASDAQ:SUPN – Get Free Report) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, earnings, risk, valuation, institutional ownership and profitability. Insider & Institutional Ownership 77.7% of Taysha […] - 2025-08-26 05:06:47
Taysha Gene Therapies (NASDAQ:TSHA) Shares Gap Up Following Analyst Upgrade
Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report)’s stock price gapped up prior to trading on Wednesday after Wells Fargo & Company raised their price target on the stock from $7.50 to $8.00. The stock had previously closed at $2.91, but opened at $3.06. Wells Fargo & Company currently has an overweight rating on […] - 2025-08-15 02:34:49
Taysha Gene Therapies (NASDAQ:TSHA) Stock Price Expected to Rise, Chardan Capital Analyst Says
Taysha Gene Therapies (NASDAQ:TSHA – Get Free Report) had its target price raised by research analysts at Chardan Capital from $9.00 to $10.00 in a research note issued on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Chardan Capital’s target price points to a potential upside of 230.03% from the company’s […] - 2025-08-14 03:14:56
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives Consensus Recommendation of “Buy” from Brokerages
Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) has been given a consensus recommendation of “Buy” by the seven analysts that are covering the company, Marketbeat Ratings reports. Seven research analysts have rated the stock with a buy rating. The average 1-year price target among brokers that have issued ratings on the stock in […] - 2025-07-14 05:38:47
Taysha Gene Therapies (NASDAQ:TSHA) and Sol-Gel Technologies (NASDAQ:SLGL) Financial Review
Taysha Gene Therapies (NASDAQ:TSHA – Get Free Report) and Sol-Gel Technologies (NASDAQ:SLGL – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, profitability, analyst recommendations, institutional ownership and valuation. Profitability This table compares Taysha Gene […] - 2025-07-02 04:22:55
Squarepoint Ops LLC Acquires 108,719 Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA)
Squarepoint Ops LLC grew its position in shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Free Report) by 105.4% in the 4th quarter, Holdings Channel reports. The firm owned 211,842 shares of the company’s stock after acquiring an additional 108,719 shares during the quarter. Squarepoint Ops LLC’s holdings in Taysha Gene Therapies were worth $366,000 […] - 2025-06-06 05:16:54
Taysha Gene Therapies (NASDAQ:TSHA) Shares Gap Up After Insider Buying Activity
Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report)’s stock price gapped up before the market opened on Wednesday after an insider bought additional shares in the company. The stock had previously closed at $2.78, but opened at $2.93. Taysha Gene Therapies shares last traded at $2.74, with a volume of 392,262 shares. Specifically, major […] - 2025-06-06 02:07:06
Nuveen Asset Management LLC Cuts Position in Taysha Gene Therapies, Inc. (NASDAQ:TSHA)
Nuveen Asset Management LLC cut its stake in Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Free Report) by 3.6% in the 4th quarter, Holdings Channel reports. The fund owned 546,414 shares of the company’s stock after selling 20,436 shares during the quarter. Nuveen Asset Management LLC’s holdings in Taysha Gene Therapies were worth $945,000 at the […] - 2025-06-05 04:56:49
BNP Paribas Financial Markets Takes $41,000 Position in Taysha Gene Therapies, Inc. (NASDAQ:TSHA)
BNP Paribas Financial Markets acquired a new stake in shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Free Report) during the 4th quarter, Holdings Channel reports. The fund acquired 23,644 shares of the company’s stock, valued at approximately $41,000. Several other institutional investors and hedge funds have also recently modified their holdings of the company. […] - 2025-06-04 05:48:46
Needham & Company LLC Reaffirms Buy Rating for Taysha Gene Therapies (NASDAQ:TSHA)
Taysha Gene Therapies (NASDAQ:TSHA – Get Free Report)‘s stock had its “buy” rating reiterated by Needham & Company LLC in a note issued to investors on Monday,Benzinga reports. They presently have a $8.00 price objective on the stock, up from their prior price objective of $6.00. Needham & Company LLC’s price target indicates a potential […] - 2025-06-04 02:42:44
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Holdings Cut by Deutsche Bank AG
Deutsche Bank AG decreased its stake in Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Free Report) by 94.1% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 151,083 shares of the company’s stock after selling 2,409,201 shares during the quarter. Deutsche Bank […] - 2025-06-02 04:52:51
JMP Securities Issues Positive Forecast for Taysha Gene Therapies (NASDAQ:TSHA) Stock Price
Taysha Gene Therapies (NASDAQ:TSHA – Free Report) had its price objective boosted by JMP Securities from $5.00 to $6.00 in a research note published on Thursday,Benzinga reports. They currently have a market outperform rating on the stock. A number of other research analysts have also issued reports on TSHA. Canaccord Genuity Group increased their target […] - 2025-05-30 04:55:04
Reviewing Taysha Gene Therapies (NASDAQ:TSHA) & Quince Therapeutics (NASDAQ:QNCX)
Taysha Gene Therapies (NASDAQ:TSHA – Get Free Report) and Quince Therapeutics (NASDAQ:QNCX – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation. Volatility and Risk Taysha Gene Therapies […] - 2025-05-28 02:50:53
Taysha Gene Therapies (NASDAQ:TSHA) vs. Black Diamond Therapeutics (NASDAQ:BDTX) Financial Comparison
Taysha Gene Therapies (NASDAQ:TSHA – Get Free Report) and Black Diamond Therapeutics (NASDAQ:BDTX – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations. Profitability This table compares Taysha […] - 2025-05-23 02:48:59
Hsbc Holdings PLC Has $36,000 Stock Position in Taysha Gene Therapies, Inc. (NASDAQ:TSHA)
Hsbc Holdings PLC lifted its holdings in shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Free Report) by 65.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 20,391 shares of the company’s stock after purchasing an additional 8,076 shares during […] - 2025-05-13 04:26:52
Marshall Wace LLP Lowers Stock Position in Taysha Gene Therapies, Inc. (NASDAQ:TSHA)
Marshall Wace LLP reduced its position in Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Free Report) by 71.6% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 138,111 shares of the company’s stock after selling 347,915 shares during the period. Marshall Wace LLP’s holdings in Taysha Gene Therapies were worth $239,000 at the end of […] - 2025-05-06 04:44:54
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Given Average Rating of “Buy” by Analysts
Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) has been given a consensus recommendation of “Buy” by the eight analysts that are covering the firm, MarketBeat Ratings reports. Eight analysts have rated the stock with a buy rating. The average twelve-month target price among brokerages that have updated their coverage on the stock in […] - 2025-05-05 04:28:56
Renaissance Technologies LLC Makes New $1.52 Million Investment in Taysha Gene Therapies, Inc. (NASDAQ:TSHA)
Renaissance Technologies LLC purchased a new stake in Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 878,448 shares of the company’s stock, valued at approximately $1,520,000. Renaissance Technologies LLC owned approximately 0.43% of Taysha Gene […] - 2025-04-28 05:05:14
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives $6.63 Consensus Price Target from Brokerages
Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) have been given a consensus rating of “Buy” by the eight brokerages that are currently covering the stock, MarketBeat Ratings reports. Eight research analysts have rated the stock with a buy rating. The average 12-month price objective among brokers that have issued ratings on […] - 2025-04-08 02:33:03
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives $6.63 Consensus Price Target from Brokerages
Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) have been given a consensus recommendation of “Buy” by the eight ratings firms that are covering the company, Marketbeat reports. Eight investment analysts have rated the stock with a buy rating. The average 12-month price objective among brokerages that have issued a report on […] - 2025-02-17 04:29:09

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) TSHA holdings

DateNumber of TSHA Shares HeldBase Market Value of TSHA SharesLocal Market Value of TSHA SharesChange in TSHA Shares HeldChange in TSHA Base ValueCurrent Price per TSHA Share HeldPrevious Price per TSHA Share Held
2025-11-11 (Tuesday)175,283USD 750,211TSHA holding increased by 68360USD 750,2110USD 68,360 USD 4.28 USD 3.89
2025-11-10 (Monday)175,283TSHA holding increased by 452USD 681,851TSHA holding increased by 12248USD 681,851452USD 12,248 USD 3.89 USD 3.83
2025-11-07 (Friday)174,831USD 669,603TSHA holding decreased by -15735USD 669,6030USD -15,735 USD 3.83 USD 3.92
2025-11-06 (Thursday)174,831TSHA holding increased by 452USD 685,338TSHA holding decreased by -17409USD 685,338452USD -17,409 USD 3.92 USD 4.03
2025-11-05 (Wednesday)174,379USD 702,747TSHA holding decreased by -41851USD 702,7470USD -41,851 USD 4.03 USD 4.27
2025-11-04 (Tuesday)174,379TSHA holding increased by 454USD 744,598TSHA holding decreased by -31108USD 744,598454USD -31,108 USD 4.27 USD 4.46
2025-11-03 (Monday)173,925USD 775,706TSHA holding decreased by -86962USD 775,7060USD -86,962 USD 4.46 USD 4.96
2025-10-31 (Friday)173,925USD 862,668TSHA holding increased by 8696USD 862,6680USD 8,696 USD 4.96 USD 4.91
2025-10-30 (Thursday)173,925TSHA holding increased by 2265USD 853,972TSHA holding decreased by -6045USD 853,9722,265USD -6,045 USD 4.91 USD 5.01
2025-10-29 (Wednesday)171,660TSHA holding increased by 906USD 860,017TSHA holding increased by 7955USD 860,017906USD 7,955 USD 5.01 USD 4.99
2025-10-28 (Tuesday)170,754USD 852,062TSHA holding increased by 18782USD 852,0620USD 18,782 USD 4.99 USD 4.88
2025-10-27 (Monday)170,754USD 833,280TSHA holding increased by 22198USD 833,2800USD 22,198 USD 4.88 USD 4.75
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of TSHA by Blackrock for IE00BDZVHG35

Show aggregate share trades of TSHA

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-10BUY452 3.890* 2.38
2025-11-06BUY452 3.920* 2.36
2025-11-04BUY454 4.270* 2.34
2025-10-30BUY2,2655.1884.905 4.933USD 11,174 2.30
2025-10-29BUY9065.0105.250 5.226USD 4,735 2.29
2025-10-22SELL-1,8084.9405.240 5.210USD -9,420 2.21 Loss of -5,419 on sale
2025-10-20BUY9044.7204.890 4.873USD 4,405 2.18
2025-10-17BUY2,2574.7204.920 4.900USD 11,059 2.17
2025-10-15BUY3,5925.3405.508 5.491USD 19,724 2.15
2025-10-03BUY3,6274.7605.400 5.336USD 19,354 2.11
2025-09-30BUY9123.2703.300 3.297USD 3,007 2.08
2025-09-26BUY9123.2503.260 3.259USD 2,972 2.07
2025-09-25BUY9123.0603.150 3.141USD 2,865 2.06
2025-09-18BUY4602.9903.040 3.035USD 1,396 2.06
2025-09-17BUY1,3862.9002.955 2.949USD 4,088 2.05
2025-07-17SELL-9082.5902.620 2.617USD -2,376 2.04 Loss of -527 on sale
2025-07-11SELL-3,6562.6402.725 2.716USD -9,932 2.02 Loss of -2,537 on sale
2025-07-02BUY25,1352.4302.505 2.498USD 62,775 2.01
2025-06-25BUY9122.4402.460 2.458USD 2,242 2.00
2025-06-20BUY26,8222.4602.619 2.603USD 69,820 1.99
2025-06-13BUY10,2832.5402.640 2.630USD 27,044 1.97
2025-06-11BUY6642.6703.010 2.976USD 1,976 1.96
2025-06-10BUY6622.6102.850 2.826USD 1,871 1.95
2025-06-04SELL-3312.7902.940 2.925USD -968 1.93 Loss of -331 on sale
2025-04-23BUY3331.8201.980 1.964USD 654 1.78
2025-04-10SELL-2,6721.1701.220 1.215USD -3,246 1.83 Profit of 1,642 on sale
2025-04-08SELL-3341.1301.290 1.274USD -426 1.84 Profit of 191 on sale
2025-04-07SELL-3341.2401.255 1.253USD -419 1.85 Profit of 200 on sale
2025-04-04SELL-1,6801.2201.240 1.238USD -2,080 1.86 Profit of 1,044 on sale
2025-04-01BUY3361.2651.420 1.404USD 472 1.87
2025-03-14SELL-5,3921.7201.780 1.774USD -9,565 1.90 Profit of 658 on sale
2025-03-07SELL-6741.7501.765 1.763USD -1,189 1.91 Profit of 98 on sale
2025-03-04SELL-3371.6301.670 1.666USD -561 1.92 Profit of 85 on sale
2025-02-25BUY6741.7001.740 1.736USD 1,170 1.94
2025-02-19SELL-3371.6401.670 1.667USD -562 1.97 Profit of 101 on sale
2025-02-13BUY1,0111.6201.660 1.656USD 1,674 2.00
2025-02-12BUY3361.6001.600 1.600USD 538 2.00
2025-02-11BUY1,3441.6001.850 1.825USD 2,453 2.01
2024-12-30SELL-17,0661.7301.760 1.757USD -29,985 2.19 Profit of 7,444 on sale
2024-11-18SELL-5,7002.2802.340 2.334USD -13,304 1.76 Loss of -3,268 on sale
2024-11-08SELL-3871.5001.520 1.518USD -587 1.73 Profit of 84 on sale
2024-10-21SELL-3872.0202.065 2.061USD -797 0.00 Loss of -797 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of TSHA

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19613,7530967,14563.5%
2025-09-18442,6160974,87445.4%
2025-09-17479,57201,359,09435.3%
2025-09-16451,8791,3001,077,17342.0%
2025-09-15628,84401,235,63950.9%
2025-09-12671,9394851,757,44638.2%
2025-09-11822,8586,1081,571,58352.4%
2025-09-10551,13087,7011,251,08544.1%
2025-09-09687,0274,4021,541,55444.6%
2025-09-08720,7513,9731,745,53941.3%
2025-09-051,048,040452,759,70238.0%
2025-09-044,516,88408,609,37252.5%
2025-09-03385,7451,800744,92651.8%
2025-09-02397,4350869,35545.7%
2025-08-29185,7910549,15433.8%
2025-08-28184,00615,000893,88720.6%
2025-08-27251,2050476,87652.7%
2025-08-26216,2470588,68636.7%
2025-08-25234,9390724,47432.4%
2025-08-22933,37201,356,57168.8%
2025-08-21402,502126,299797,20450.5%
2025-08-20327,9793,500662,06949.5%
2025-08-191,076,37401,499,00971.8%
2025-08-18510,5725041,025,77549.8%
2025-08-15637,008361,108,96957.4%
2025-08-14340,31501,113,99330.5%
2025-08-13479,3961,8602,251,40321.3%
2025-08-12568,0085002,317,99024.5%
2025-08-11505,382951,158,49143.6%
2025-08-08157,3880392,51140.1%
2025-08-07255,871200681,09537.6%
2025-08-06415,340106706,60458.8%
2025-08-05390,6291011,268,10330.8%
2025-08-04449,85701,069,39342.1%
2025-08-01516,3327961,223,86942.2%
2025-07-31305,121100558,82854.6%
2025-07-30498,83301,678,53229.7%
2025-07-29296,823640749,41739.6%
2025-07-28360,35192566,55963.6%
2025-07-25323,165378508,77363.5%
2025-07-24381,646100562,62067.8%
2025-07-23570,7802,2621,274,77844.8%
2025-07-221,070,8661,8621,992,80553.7%
2025-07-21523,552351893,55258.6%
2025-07-18537,64001,202,42144.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.